grey market retatrutide WITHOUT Compromises 👀 #retatrutide #glp1 ⚠️ BEWARE OF RETATRUTIDE SOLD

Retatrutide is a triple agonist: it works on three (GLP-1, GIP, and glucagon)

Two options are approved: Wegovy (weekly) and Saxenda (daily)

In comparable trials of injectable GLP1 drugs from Eli Lilly, average weight loss has generally fallen in the 15-20% range over a similar time frame

Social media claims that people can build muscle because retatrutide burns fat better oversimplify the science

The Future of ROSE-010 in IBS Upcoming Phase 2b Trial: Focus on IBS-C & IBS-M (most responsive groups) Patients will self-inject during pain attacks Pain measured using standardized numeric pain scale

141 Management of multiple liver etiologies of MASLD is therefore an important aspect of avoiding adverse clinical outcomes